Sanofi (SNY)

Last Price: 50.79 (2020-09-24)

Company Description

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $40.00B
Net Income (Most Recent Fiscal Year) $3.26B
PE Ratio (Current Year Earnings Estimate) 14.53
PE Ratio (Trailing 12 Months) 15.06
PEG Ratio (Long Term Growth Estimate) 1.87
Price to Sales Ratio (Trailing 12 Months) 3.16
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.81
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 7.62
Pre-Tax Margin (Trailing 12 Months) 7.50%
Net Margin (Trailing 12 Months) 13.88%
Return on Equity (Trailing 12 Months) 24.71%
Return on Assets (Trailing 12 Months) 13.25%
Current Ratio (Most Recent Fiscal Quarter) 1.85
Quick Ratio (Most Recent Fiscal Quarter) 1.38
Debt to Common Equity (Most Recent Fiscal Quarter) 0.34
Inventory Turnover (Trailing 12 Months) 2.91
Book Value per Share (Most Recent Fiscal Quarter) $26.44
Earnings per Share (Most Recent Fiscal Quarter) $0.65
Earnings per Share (Most Recent Fiscal Year) $3.32
Diluted Earnings per Share (Trailing 12 Months) $2.26
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 2.50B
Free Float 2.48B
Market Capitalization $126.73B
Average Volume (Last 20 Days) 0.91M
Beta (Past 60 Months) 0.52
Percentage Held By Insiders (Latest Annual Proxy Report) 1.00%
Percentage Held By Institutions (Latest 13F Reports) 7.15%
Annual Dividend (Based on Last Quarter) $1.17
Dividend Yield (Based on Last Quarter) 2.32%